A clinical overview of monoamine oxidase inhibitors.
D000929:Antidepressive Agents, Tricyclic / Q000494:pharmacology; D001008:Anxiety Disorders / Q000150:complications / Q000188:drug therapy; D001835:Body Weight / Q000187:drug effects; D003866:Depressive Disorder / Q000150:complications / Q000188:drug therapy; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D007024:Hypotension, Orthostatic / Q000139:chemically induced; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D010624:Phenelzine / Q000627:therapeutic use; D010698:Phobic Disorders / Q000188:drug therapy; D014439:Tyramine / Q000009:adverse effects
D000929:Antidepressive Agents, Tricyclic; D008996:Monoamine Oxidase Inhibitors; D010624:Phenelzine; D014439:Tyramine